PULMATRIX, INC. Variable Lease, Cost
PULMATRIX, INC. (PULM) reported Variable Lease, Cost of $214.00 thousand for the 12-month period ending 2024-12-31, per its S-4/A filed 2026-09-17.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-09-17
- PULMATRIX, INC. variable lease, cost for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- PULMATRIX, INC. variable lease, cost for the quarter ending 2024-09-30 was $8.00K, a 96.06% decline year-over-year.
- PULMATRIX, INC. variable lease, cost for the quarter ending 2024-06-30 was $104.00K, a 38.10% decline year-over-year.
- PULMATRIX, INC. variable lease, cost for the quarter ending 2024-03-31 was $102.00K, a 9.73% decline year-over-year.
- PULMATRIX, INC. variable lease, cost for fiscal 2023 was $593.00K, a 14.68% decline from fiscal 2022.
- PULMATRIX, INC. variable lease, cost for fiscal 2022 was $695.00K, a 66.67% increase from fiscal 2021.
- PULMATRIX, INC. variable lease, cost for fiscal 2021 was $417.00K, a 0.95% decline from fiscal 2020.
- PULMATRIX, INC. variable lease, cost for fiscal 2020 was $421.00K, a 10.50% increase from fiscal 2019.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: S-4/A 12 month − 10-Q 9 month · filed 2026-09-17 | $8.00K derived: sum of 2 quarters · filed 2026-09-17 | $112.00K derived: sum of 3 quarters · filed 2026-09-17 | $214.00K S-4/A · filed 2026-09-17 |
| 2024-09-30 | $8.00K 10-Q · filed 2024-11-08 | $112.00K derived: sum of 2 quarters · filed 2024-11-08 | $214.00K 10-Q · filed 2024-11-08 | $323.00K derived: sum of 4 quarters · filed 2025-03-21 |
| 2024-06-30 | $104.00K 10-Q · filed 2024-08-13 | $206.00K 10-Q · filed 2024-08-13 | $315.00K derived: sum of 3 quarters · filed 2025-03-21 | $518.00K derived: sum of 4 quarters · filed 2025-03-21 |
| 2024-03-31 | $102.00K 10-Q · filed 2024-05-10 | $211.00K derived: sum of 2 quarters · filed 2025-03-21 | $414.00K derived: sum of 3 quarters · filed 2025-03-21 | $582.00K derived: sum of 4 quarters · filed 2025-03-21 |
| 2023-12-31 | $109.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | $312.00K derived: sum of 2 quarters · filed 2025-03-21 | $480.00K derived: sum of 3 quarters · filed 2025-03-21 | $593.00K 10-K · filed 2025-03-21 |
| 2023-09-30 | $203.00K 10-Q · filed 2024-11-08 | $371.00K derived: sum of 2 quarters · filed 2024-11-08 | $484.00K 10-Q · filed 2024-11-08 | $623.00K derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $168.00K 10-Q · filed 2024-08-13 | $281.00K 10-Q · filed 2024-08-13 | $420.00K derived: sum of 3 quarters · filed 2024-08-13 | $626.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $113.00K 10-Q · filed 2024-05-10 | $252.00K derived: sum of 2 quarters · filed 2024-05-10 | $458.00K derived: sum of 3 quarters · filed 2024-05-10 | $604.00K derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $139.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $345.00K derived: sum of 2 quarters · filed 2024-03-28 | $491.00K derived: sum of 3 quarters · filed 2024-03-28 | $695.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | $206.00K 10-Q · filed 2023-11-09 | $352.00K derived: sum of 2 quarters · filed 2023-11-09 | $556.00K 10-Q · filed 2023-11-09 | $654.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $146.00K 10-Q · filed 2023-08-10 | $350.00K 10-Q · filed 2023-08-10 | $448.00K derived: sum of 3 quarters · filed 2023-08-10 | $545.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $204.00K 10-Q · filed 2023-05-12 | $302.00K derived: sum of 2 quarters · filed 2023-05-12 | $399.00K derived: sum of 3 quarters · filed 2023-05-12 | $495.00K derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $98.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $195.00K derived: sum of 2 quarters · filed 2023-03-30 | $291.00K derived: sum of 3 quarters · filed 2023-03-30 | $417.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | $97.00K 10-Q · filed 2022-11-10 | $193.00K derived: sum of 2 quarters · filed 2022-11-10 | $319.00K 10-Q · filed 2022-11-10 | $423.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $96.00K 10-Q · filed 2022-08-10 | $222.00K 10-Q · filed 2022-08-10 | $326.00K derived: sum of 3 quarters · filed 2022-08-10 | $425.00K derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $126.00K 10-Q · filed 2022-05-12 | $230.00K derived: sum of 2 quarters · filed 2022-05-12 | $329.00K derived: sum of 3 quarters · filed 2022-05-12 | $428.00K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $104.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $203.00K derived: sum of 2 quarters · filed 2022-03-29 | $302.00K derived: sum of 3 quarters · filed 2022-03-29 | $421.00K 10-K · filed 2022-03-29 |
| 2020-09-30 | $99.00K 10-Q · filed 2021-11-10 | $198.00K derived: sum of 2 quarters · filed 2021-11-10 | $317.00K 10-Q · filed 2021-11-10 | $414.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $99.00K 10-Q · filed 2021-08-10 | $218.00K 10-Q · filed 2021-08-10 | $315.00K derived: sum of 3 quarters · filed 2021-08-10 | $412.00K derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | $119.00K 10-Q · filed 2021-05-11 | $216.00K derived: sum of 2 quarters · filed 2021-05-11 | $313.00K derived: sum of 3 quarters · filed 2021-05-11 | $403.00K derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | $97.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | $194.00K derived: sum of 2 quarters · filed 2021-03-23 | $284.00K derived: sum of 3 quarters · filed 2021-03-23 | $381.00K 10-K · filed 2021-03-23 |
| 2019-09-30 | $97.00K 10-Q · filed 2020-11-12 | $187.00K derived: sum of 2 quarters · filed 2020-11-12 | $284.00K 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $90.00K 10-Q · filed 2020-08-07 | $187.00K 10-Q · filed 2020-08-07 | ||
| 2019-03-31 | $97.00K 10-Q · filed 2020-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |